Kevin Winthrop

CRISPR Detection of Circulating Cell-Free Mycobacterium Avium Complex (MAC) DNA for Rapid Diagnosis and Monitoring of MAC Pulmonary Disease

National Institute of Allergy and Infectious Diseases · R01

Contact PI · $2.3M · Oregon Health & Science University

Phase 2 Study of the Efficacy and Safety of ORC-13661 for the Prevention of Ototoxicity in Patients Receiving Intravenous Amikacin for Treatment of Non-Tuberculous Mycobacterium Infection

National Institute on Deafness and Other Communication Disorders · U01

Contact PI · $4.1M · Oregon Health & Science University

Mycobacterium Avium Complex Pulmonary Infection: Immunologic and Transcriptomic Signatures of Disease and Treatment Response

National Institute of Allergy and Infectious Diseases · R01

Contact PI · $3.2M · Oregon Health & Science University

Novel Strategies for Treatment of Mycobacterium Abscessus Pulmonary Disease

National Institute of Allergy and Infectious Diseases · R34

PI · $240.9K · Medical University of South Carolina

Epetraborole in Patients With Mycobacterium Abscessus Lung Disease

Principal investigator · Recruiting · Phase 2

Kevin Winthrop

Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin

Principal investigator · Recruiting · Phase 2

Kevin Winthrop

Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease

Principal investigator · Completed · Phase 2, Phase 3

Kevin Winthrop

Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)

Principal investigator · Active not recruiting · Phase 2

Oregon Health and Science University